EBD Group and MassBio today announced that Angus Russell, CEO of Shire,
will be the keynote speaker at BioPharm America™, being held in Boston
at the Westin Waterfront, September 7-9, 2011. With more than 1,000
dealmakers expected, the 2011 edition of BioPharm America promises to be
one of the most productive partnering events of the year for the biotech
"Partnering is a central strategy for success in today's biotech
industry, and as the industry continues to shift around personalized
medicine, establishing the right partnerships is more important than
ever," said Russell. "BioPharm America 2011 provides an exceptional
opportunity for companies representing the biotech industry value chain
to identify new opportunities, and start the conversations that lead to
tomorrow's partnerships and acquisitions."
A highly regarded leader in the life science industry, Russell has been
CEO of Shire since 2008 and has been a member of the board since 1999.
He was the company's CFO from December 1999 to June 2008, and is also
the chairman of the company's leadership team. Between 1980 and 1999, he
held a number of positions of increasing responsibility at ICI, Zeneca
and AstraZeneca PLC, including VP, Corporate Finance at AstraZeneca and
Group Treasurer at Zeneca.
"We're honored to have Angus Russell sharing his insights at BioPharm
America," said Carola Schropp, President of EBD Group, organizers of the
conference. "This year's edition is attracting a notable group of large
pharma, innovative development stage companies and leading financiers,
and again will turn Boston into the hub of life science dealmaking."
Robert K. Coughlin, President and CEO of the event's host organization,
MassBio, added, "More and more, collaboration between pharma, biotech,
venture and academia proves to be the model for moving innovation out of
the lab and into the market. BioPharm America continues to be a venue
where those collaborations begin."
MassBio, a not-for-profit organization that represents and provides
services and support for the Massachusetts biotechnology industry, is
the nation's oldest biotechnology trade associatin. Founded in 1985,
MassBio is committed to advancing the development of critical new
science, technology and medicines that benefit people worldwide.
Representing over 600 biotechnology companies, academic institutions,
research hospitals, and service organizations involved in life sciences
and health care, MassBio works to advance policy and promote education,
while providing member programs and events, industry information, and
For more information please visit www.massbio.org.
About EBD Group
EBD Group is the leading partnering firm for the global life science
industry. Since 1993, biotech, pharma and medical device companies have
leveraged EBD Group's partnering conferences, technology and services to
identify business opportunities and develop strategic relationships
essential to their success.
EBD Group's conferences are run with the support of leading corporations
and international trade associations and include:
EBD Group's sophisticated web-based partnering service, partneringONE®,
is used as the partnering engine at numerous third-party events around
Outside of the conference format, EBD Group's consultants provide
hands-on assistance for firms seeking to in- or out-license products and
EBD Group has offices in the USA and Europe.
For more information please visit www.ebdgroup.com.
[ Back To NFVZone's Homepage ]